跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TADALAFIL TABLETS USP 20MG - PPB Drug Approval Details
Approvals
/
PPB
/
TADALAFIL TABLETS USP 20MG
Approved
STANDARD
TADALAFIL TABLETS USP 20MG
BRIGHT FUTURE PHARMACEUTICALS FACTORY O/B BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Dec 24, 2025
Approval ID
d5547e15df69a5f0
Company
BRIGHT FUTURE PHARMACEUTICALS FACTORY O/B BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Type
Standard
Approval Details
Approval Id
d5547e15df69a5f0
Product Name
TADALAFIL TABLETS USP 20MG
Drug Hk Name
TADALAFIL TABLETS USP 20MG
Registration Code
HK-68940
Company Name
BRIGHT FUTURE PHARMACEUTICALS FACTORY O/B BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2025-12-16
Company Address
BF PHARMACEUTICAL CTR NO.1 & 8 WANG FU ST, YUEN LONG INDUSTRIAL ESTATE, YUEN LONG, NEW TERRITORIES
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Dec 24, 2025
Approval ID
d5547e15df69a5f0
Type
Standard
Back to PPB Approvals